Recent advances in the treatment of diabetes mellitus - what is available and what is foreseeable

Abstract

In 2006, Czech patients had their first opportunity to test new insulin delivery systems such as insulin pens and insulin pumps providing the possibility of continuous monitoring of glycemia. Since the very beginning of January 2007, the portfolio of insulins marketed in the Czech Republic was broadened to include other biphasic insulin analogues in two variants and a new thiazolidinedione derivative, pioglitazone, was also launched.

The advent of inhaled insulins and exenatide is foreseen during 2007.

Keywords

• continuous blood glucose monitoring
• insulin analogs
• inhaled insulin
• thiazolidinediones